CPDC annonce la nomination du Dr John Valliant au poste de président du conseil d’administration

Hamilton, Ontario –  le 19 octobre 2026 – Le CPDC (Centre for Probe Development and Commercialization) a annoncé aujourd’hui la nomination du Dr John Valliant à titre de président de son conseil d’administration. Le Dr Valliant succède à Damian Lamb, qui continuera de siéger au conseil à titre d’administrateur. En 2008, alors qu’il était professeur … Read more

CPDC annonce la nomination de la Dre Lana Janes au poste de directrice scientifique

HAMILTON, Ontario – le 16 octobre 2026 – CPDC (Centre for Probe Development and Commercialization) est heureux d’annoncer la nomination de la Dre Lana Janes au poste de directrice scientifique de l’entreprise, à compter du 16 octobre 2026. Membre du conseil d’administration de CPDC depuis 2021, la Dre Janes a assuré un leadership stratégique au … Read more

CPDC Announces the Appointment of Dr. Lana Janes as Chief Scientific Officer

HAMILTON, ON – October 16, 2026 – CPDC (Centre for Probe Development and Commercialization) is pleased to announce the appointment of Dr. Lana Janes as Chief Scientific Officer of the company, effective October 16, 2026. Dr. Janes has served on CPDC’s Board of Directors since 2021, providing strategic leadership during a period of significant changes … Read more

Appel à idées : Nouvelles approches canadiennes en radiopharmaceutiques 2026

CQDM and CPDC are pleased to announce the launch of the 2026 Call for Ideas: New Canadian Approaches in Radiopharmaceuticals, a national initiative designed to identify and support innovative Canadian technologies, discoveries, and companies that can contribute to the next generation of radiopharmaceuticals. Canada has developed internationally recognized expertise across the radiopharmaceutical value chain, from … Read more

Le CPDC annonce un remaniement au sein de son conseil d’administration et la nomination d’un nouveau président

Hamilton, Ontario — 8 juillet 2026 — Le CPDC a annoncé aujourd’hui qu’après 18 ans passés à la tête de l’organisation, le Dr John Thornback a décidé de prendre sa retraite en tant que président et de quitter le conseil d’administration. Le conseil d’administration a nommé Damian Lamb au poste de président ; celui-ci siège … Read more

CPDC lance Cadena Research, une ORC préclinique spécialisée dans les produits radiopharmaceutiques

Cadena Research soutient les innovateurs dans le domaine des produits radiopharmaceutiques en leur proposant des solutions sur mesure qui accélèrent le passage à la phase clinique. Hamilton, Ontario – 29 septembre 2025 – CPDC, leader mondial dans le développement et la commercialisation de produits radiopharmaceutiques, est fier d’annoncer le lancement de Cadena Research, une nouvelle … Read more

CPDC Announces Seed Investment in Radiosyn Ltd.

HAMILTON, ON, June 12, 2025 – CPDC, a global leader in the development and commercialization of radiopharmaceuticals, today announced a $650,000 seed investment in RadioSyn Ltd., a Hamilton-based startup company developing a miniaturized automated radiopharmaceutical synthesis device. The shielded synthesizer uses disposable microfluidic chips to perform end-to-end chemical and radiochemical reactions to synthesize radiopharmaceuticals at … Read more

Lab2Market Partners with CPDC to Launch L2M Discover Radiopharma Program

HAMILTON, ON, June 12, 2025 – CPDC and Lab2Market (L2M) today announced the L2M Discover Radiopharma program, a groundbreaking initiative to cultivate entrepreneurial skills among Canadian researchers in the radiopharmaceutical sector. Beginning on September 16, 2025, the 10-week virtual training program will equip students and faculty with the foundational tools necessary to embark on their … Read more

Call for Ideas: New Canadian Approaches in Radiopharmaceuticals

CQDM and the Centre for Probe Development and Commercialization (CPDC) are pleased to announce a strategic initiative  to support the development of next-generation radiopharmaceuticals in Canada. This collaboration represents a unique opportunity to align Canada’s strengths and global expertise in this expanding field. Together we are initiating a collective effort that will foster innovation and growth, and we … Read more

1st Annual CMIE-CNIC Symposium on Medical Isotopes a Resounding Success in Vancouver – CMIE

Vancouver, B.C. – December 17, 2024 – The inaugural Symposium on Medical Isotopes, hosted by the Canadian Medical Isotope Ecosystem (CMIE) in partnership with the Canadian Nuclear Isotope Council (CNIC), took place on December 12-13, 2024, at the Holiday Inn & Suites in Vancouver. The event attracted over 70 key stakeholders from across Canada’s medical isotope … Read more